| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | disaccharide binding | 1.07e-07 | 7 | 30 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | galactoside binding | 2.55e-07 | 9 | 30 | 3 | GO:0016936 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 3.43e-06 | 20 | 30 | 3 | GO:0070492 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 2.16e-04 | 78 | 30 | 3 | GO:0043539 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 9.99e-09 | 4 | 29 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 1.39e-07 | 8 | 29 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell migration | 3.08e-07 | 41 | 29 | 4 | GO:2000406 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte migration | 6.39e-07 | 49 | 29 | 4 | GO:2000403 | |
| GeneOntologyBiologicalProcess | regulation of T cell migration | 1.10e-06 | 56 | 29 | 4 | GO:2000404 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 1.12e-06 | 15 | 29 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 1.12e-06 | 15 | 29 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 1.68e-06 | 17 | 29 | 3 | GO:0043301 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 2.01e-06 | 18 | 29 | 3 | GO:0043320 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 2.39e-06 | 19 | 29 | 3 | GO:0046642 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 2.39e-06 | 19 | 29 | 3 | GO:1900426 | |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 2.80e-06 | 20 | 29 | 3 | GO:0010819 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 3.27e-06 | 21 | 29 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte migration | 3.97e-06 | 77 | 29 | 4 | GO:2000401 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 4.12e-06 | 313 | 29 | 6 | GO:0098742 | |
| GeneOntologyBiologicalProcess | T cell migration | 4.86e-06 | 81 | 29 | 4 | GO:0072678 | |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 6.36e-06 | 26 | 29 | 3 | GO:1900424 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell proliferation | 7.99e-06 | 28 | 29 | 3 | GO:2000561 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell proliferation | 9.89e-06 | 30 | 29 | 3 | GO:0035739 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 1.09e-05 | 31 | 29 | 3 | GO:1901623 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 1.09e-05 | 31 | 29 | 3 | GO:0045591 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 1.21e-05 | 32 | 29 | 3 | GO:1903306 | |
| GeneOntologyBiologicalProcess | positive regulation of mononuclear cell migration | 1.31e-05 | 104 | 29 | 4 | GO:0071677 | |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 1.33e-05 | 33 | 29 | 3 | GO:0010818 | |
| GeneOntologyBiologicalProcess | maintenance of protein location | 1.76e-05 | 112 | 29 | 4 | GO:0045185 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation in thymus | 1.88e-05 | 37 | 29 | 3 | GO:0033081 | |
| GeneOntologyBiologicalProcess | lymphocyte migration | 2.02e-05 | 116 | 29 | 4 | GO:0072676 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 2.04e-05 | 38 | 29 | 3 | GO:0001779 | |
| GeneOntologyBiologicalProcess | female pregnancy | 2.31e-05 | 249 | 29 | 5 | GO:0007565 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 2.38e-05 | 40 | 29 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell activation | 2.38e-05 | 40 | 29 | 3 | GO:2000515 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 2.57e-05 | 41 | 29 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 2.76e-05 | 42 | 29 | 3 | GO:0002323 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 2.76e-05 | 42 | 29 | 3 | GO:0043032 | |
| GeneOntologyBiologicalProcess | positive regulation of SMAD protein signal transduction | 2.97e-05 | 43 | 29 | 3 | GO:0060391 | |
| GeneOntologyBiologicalProcess | negative regulation of exocytosis | 3.41e-05 | 45 | 29 | 3 | GO:0045920 | |
| GeneOntologyBiologicalProcess | positive regulation of oxidoreductase activity | 3.64e-05 | 46 | 29 | 3 | GO:0051353 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 3.89e-05 | 47 | 29 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 type immune response | 3.89e-05 | 47 | 29 | 3 | GO:2000316 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-10 production | 4.14e-05 | 48 | 29 | 3 | GO:0032733 | |
| GeneOntologyBiologicalProcess | regulation of regulatory T cell differentiation | 4.41e-05 | 49 | 29 | 3 | GO:0045589 | |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 4.78e-05 | 290 | 29 | 5 | GO:0044703 | |
| GeneOntologyBiologicalProcess | negative regulation of type II interferon production | 4.97e-05 | 51 | 29 | 3 | GO:0032689 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 5.10e-05 | 294 | 29 | 5 | GO:0044706 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 5.27e-05 | 52 | 29 | 3 | GO:0031342 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell activation | 5.27e-05 | 52 | 29 | 3 | GO:0046636 | |
| GeneOntologyBiologicalProcess | lymphocyte chemotaxis | 5.58e-05 | 53 | 29 | 3 | GO:0048247 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell proliferation | 5.58e-05 | 53 | 29 | 3 | GO:0046640 | |
| GeneOntologyBiologicalProcess | regulatory T cell differentiation | 5.91e-05 | 54 | 29 | 3 | GO:0045066 | |
| GeneOntologyBiologicalProcess | regulation of type II interferon production | 6.29e-05 | 155 | 29 | 4 | GO:0032649 | |
| GeneOntologyBiologicalProcess | regulation of mononuclear cell migration | 7.12e-05 | 160 | 29 | 4 | GO:0071675 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell proliferation | 7.70e-05 | 59 | 29 | 3 | GO:0046633 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 8.51e-05 | 61 | 29 | 3 | GO:0032814 | |
| GeneOntologyBiologicalProcess | type II interferon production | 8.80e-05 | 169 | 29 | 4 | GO:0032609 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte degranulation | 9.38e-05 | 63 | 29 | 3 | GO:0043300 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 9.38e-05 | 63 | 29 | 3 | GO:0007157 | |
| GeneOntologyBiologicalProcess | T-helper 17 type immune response | 9.83e-05 | 64 | 29 | 3 | GO:0072538 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte migration | 1.10e-04 | 179 | 29 | 4 | GO:0002687 | |
| GeneOntologyBiologicalProcess | negative regulation of transport | 1.41e-04 | 587 | 29 | 6 | GO:0051051 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-10 production | 1.51e-04 | 74 | 29 | 3 | GO:0032653 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 1.64e-04 | 76 | 29 | 3 | GO:0042269 | |
| GeneOntologyBiologicalProcess | interleukin-10 production | 1.70e-04 | 77 | 29 | 3 | GO:0032613 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.91e-04 | 80 | 29 | 3 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of macrophage activation | 1.98e-04 | 81 | 29 | 3 | GO:0043030 | |
| GeneOntologyBiologicalProcess | maintenance of location | 2.07e-04 | 396 | 29 | 5 | GO:0051235 | |
| GeneOntologyBiologicalProcess | receptor clustering | 2.13e-04 | 83 | 29 | 3 | GO:0043113 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 2.13e-04 | 83 | 29 | 3 | GO:0002707 | |
| GeneOntologyBiologicalProcess | positive regulation of chemokine production | 2.21e-04 | 84 | 29 | 3 | GO:0032722 | |
| GeneOntologyBiologicalProcess | regulation of oxidoreductase activity | 2.21e-04 | 84 | 29 | 3 | GO:0051341 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-1 production | 2.53e-04 | 88 | 29 | 3 | GO:0032732 | |
| GeneOntologyBiologicalProcess | regulation of SMAD protein signal transduction | 2.70e-04 | 90 | 29 | 3 | GO:0060390 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 2.70e-04 | 90 | 29 | 3 | GO:0098586 | |
| GeneOntologyBiologicalProcess | regulation of vesicle-mediated transport | 2.81e-04 | 667 | 29 | 6 | GO:0060627 | |
| GeneOntologyBiologicalProcess | regulation of tumor necrosis factor production | 2.87e-04 | 230 | 29 | 4 | GO:0032680 | |
| GeneOntologyBiologicalProcess | regulation of tumor necrosis factor superfamily cytokine production | 3.17e-04 | 236 | 29 | 4 | GO:1903555 | |
| GeneOntologyBiologicalProcess | regulation of trophoblast cell migration | 3.22e-04 | 19 | 29 | 2 | GO:1901163 | |
| GeneOntologyBiologicalProcess | tumor necrosis factor production | 3.22e-04 | 237 | 29 | 4 | GO:0032640 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 3.27e-04 | 96 | 29 | 3 | GO:0002704 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response | 3.32e-04 | 239 | 29 | 4 | GO:0050777 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 3.49e-04 | 242 | 29 | 4 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 3.49e-04 | 242 | 29 | 4 | GO:1903708 | |
| GeneOntologyBiologicalProcess | tumor necrosis factor superfamily cytokine production | 3.54e-04 | 243 | 29 | 4 | GO:0071706 | |
| GeneOntologyBiologicalProcess | trophoblast cell migration | 3.57e-04 | 20 | 29 | 2 | GO:0061450 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell activation | 3.69e-04 | 100 | 29 | 3 | GO:2000514 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 4.06e-04 | 252 | 29 | 4 | GO:0002819 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 4.25e-04 | 105 | 29 | 3 | GO:0042267 | |
| GeneOntologyBiologicalProcess | mononuclear cell migration | 4.44e-04 | 258 | 29 | 4 | GO:0071674 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 4.50e-04 | 107 | 29 | 3 | GO:0042130 | |
| GeneOntologyBiologicalProcess | leukocyte degranulation | 4.62e-04 | 108 | 29 | 3 | GO:0043299 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 4.75e-04 | 109 | 29 | 3 | GO:0002228 | |
| GeneOntologyBiologicalProcess | SMAD protein signal transduction | 4.87e-04 | 110 | 29 | 3 | GO:0060395 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte migration | 5.05e-04 | 267 | 29 | 4 | GO:0002685 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 5.41e-04 | 114 | 29 | 3 | GO:0045824 | |
| GeneOntologyBiologicalProcess | T cell differentiation in thymus | 5.41e-04 | 114 | 29 | 3 | GO:0033077 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 5.55e-04 | 115 | 29 | 3 | GO:0090100 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 5.72e-04 | 276 | 29 | 4 | GO:0007179 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | 5.88e-04 | 1077 | 29 | 7 | GO:0098609 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-6 production | 6.59e-04 | 122 | 29 | 3 | GO:0032755 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 6.91e-04 | 124 | 29 | 3 | GO:0030101 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 6.91e-04 | 124 | 29 | 3 | GO:0050672 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.91e-04 | 656 | 30 | 6 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.96e-04 | 658 | 30 | 6 | GO:0030312 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 8.67e-04 | 530 | 30 | 5 | GO:0062023 | |
| MousePheno | enhanced humoral immune response | 2.98e-06 | 17 | 24 | 3 | MP:0020155 | |
| MousePheno | increased T-helper 1 cell number | 4.23e-06 | 19 | 24 | 3 | MP:0008086 | |
| MousePheno | increased spleen germinal center size | 7.70e-06 | 23 | 24 | 3 | MP:0008483 | |
| MousePheno | abnormal lymph node germinal center morphology | 7.70e-06 | 23 | 24 | 3 | MP:0008522 | |
| MousePheno | abnormal T-helper 1 cell number | 8.79e-06 | 24 | 24 | 3 | MP:0008085 | |
| MousePheno | abnormal lymph node secondary follicle morphology | 9.98e-06 | 25 | 24 | 3 | MP:0002346 | |
| MousePheno | abnormal spleen size | LGALS9C ZNF236 LGALS9B ITGB3 FBXW12 DAGLA ATP4A CHD5 EPHA3 LGALS9 | 1.37e-05 | 1203 | 24 | 10 | MP:0002224 |
| MousePheno | lymph node hyperplasia | 2.35e-05 | 33 | 24 | 3 | MP:0008102 | |
| MousePheno | thymus hyperplasia | 2.57e-05 | 34 | 24 | 3 | MP:0000708 | |
| MousePheno | increased susceptibility to induced arthritis | 3.06e-05 | 36 | 24 | 3 | MP:0003724 | |
| MousePheno | abnormal lymph node B cell domain morphology | 5.62e-05 | 44 | 24 | 3 | MP:0002344 | |
| MousePheno | enlarged spleen | 6.13e-05 | 862 | 24 | 8 | MP:0000691 | |
| MousePheno | abnormal T-helper 1 cell morphology | 7.31e-05 | 48 | 24 | 3 | MP:0002433 | |
| MousePheno | abnormal lymph node cortex morphology | 8.27e-05 | 50 | 24 | 3 | MP:0002343 | |
| MousePheno | increased T-helper cell number | 1.16e-04 | 56 | 24 | 3 | MP:0013763 | |
| MousePheno | decreased regulatory T cell number | 1.73e-04 | 64 | 24 | 3 | MP:0004974 | |
| MousePheno | visceromegaly | 2.14e-04 | 1030 | 24 | 8 | MP:0013328 | |
| MousePheno | increased B cell proliferation | 2.77e-04 | 75 | 24 | 3 | MP:0005154 | |
| MousePheno | abnormal Peyer's patch morphology | 3.73e-04 | 83 | 24 | 3 | MP:0000696 | |
| MousePheno | abnormal gut-associated lymphoid tissue morphology | 4.00e-04 | 85 | 24 | 3 | MP:0002378 | |
| MousePheno | spleen hyperplasia | 4.00e-04 | 85 | 24 | 3 | MP:0000693 | |
| MousePheno | abnormal skeleton physiology | 5.58e-04 | 632 | 24 | 6 | MP:0001533 | |
| MousePheno | abnormal CD4-positive helper T cell morphology | 6.45e-04 | 100 | 24 | 3 | MP:0010183 | |
| MousePheno | abnormal spleen germinal center morphology | 7.85e-04 | 107 | 24 | 3 | MP:0002359 | |
| MousePheno | autoimmune arthritis | 8.07e-04 | 108 | 24 | 3 | MP:0002993 | |
| MousePheno | abnormal spleen secondary B follicle morphology | 8.28e-04 | 109 | 24 | 3 | MP:0008472 | |
| MousePheno | abnormal T-helper cell number | 9.44e-04 | 114 | 24 | 3 | MP:0013761 | |
| MousePheno | abnormal regulatory T cell number | 9.68e-04 | 115 | 24 | 3 | MP:0004972 | |
| MousePheno | abnormal regulatory T cell morphology | 1.02e-03 | 117 | 24 | 3 | MP:0004941 | |
| MousePheno | joint inflammation | 1.41e-03 | 131 | 24 | 3 | MP:0002933 | |
| MousePheno | enlarged thymus | 1.42e-03 | 292 | 24 | 4 | MP:0000709 | |
| MousePheno | enlarged stomach | 1.44e-03 | 33 | 24 | 2 | MP:0003883 | |
| MousePheno | abnormal spleen B cell follicle morphology | 1.85e-03 | 144 | 24 | 3 | MP:0008470 | |
| MousePheno | abnormal joint physiology | 1.89e-03 | 145 | 24 | 3 | MP:0031169 | |
| MousePheno | abnormal T-helper cell morphology | 2.04e-03 | 149 | 24 | 3 | MP:0013760 | |
| MousePheno | abnormal B cell proliferation | 2.16e-03 | 152 | 24 | 3 | MP:0005153 | |
| MousePheno | abnormal zygomatic bone morphology | 2.22e-03 | 41 | 24 | 2 | MP:0005270 | |
| MousePheno | increased susceptibility to autoimmune disorder | 2.28e-03 | 155 | 24 | 3 | MP:0005350 | |
| Domain | Gal-bind_lectin | 1.68e-06 | 15 | 30 | 3 | SM00908 | |
| Domain | GALECTIN | 1.68e-06 | 15 | 30 | 3 | PS51304 | |
| Domain | Galectin_CRD | 1.68e-06 | 15 | 30 | 3 | IPR001079 | |
| Domain | Gal-bind_lectin | 1.68e-06 | 15 | 30 | 3 | PF00337 | |
| Domain | GLECT | 1.68e-06 | 15 | 30 | 3 | SM00276 | |
| Domain | ConA-like_dom | 3.97e-04 | 219 | 30 | 4 | IPR013320 | |
| Domain | - | 4.69e-04 | 95 | 30 | 3 | 2.60.120.200 | |
| Domain | Cadherin_C_2 | 2.06e-03 | 42 | 30 | 2 | PF16492 | |
| Domain | Cadherin_C | 2.06e-03 | 42 | 30 | 2 | IPR032455 | |
| Domain | Cadherin_N | 4.87e-03 | 65 | 30 | 2 | IPR013164 | |
| Domain | Cadherin_2 | 4.87e-03 | 65 | 30 | 2 | PF08266 | |
| Domain | - | 5.50e-03 | 449 | 30 | 4 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 5.95e-03 | 459 | 30 | 4 | IPR013083 | |
| Domain | PHD | 6.44e-03 | 75 | 30 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 7.12e-03 | 79 | 30 | 2 | IPR019787 | |
| Domain | EGF_2 | 8.64e-03 | 265 | 30 | 3 | PS01186 | |
| Domain | PHD | 8.96e-03 | 89 | 30 | 2 | SM00249 | |
| Domain | Znf_PHD | 9.35e-03 | 91 | 30 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.02e-02 | 95 | 30 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 1.04e-02 | 96 | 30 | 2 | PS01359 | |
| Domain | Cadherin_CS | 1.32e-02 | 109 | 30 | 2 | IPR020894 | |
| Domain | Cadherin | 1.41e-02 | 113 | 30 | 2 | PF00028 | |
| Domain | CADHERIN_1 | 1.41e-02 | 113 | 30 | 2 | PS00232 | |
| Domain | CADHERIN_2 | 1.44e-02 | 114 | 30 | 2 | PS50268 | |
| Domain | - | 1.44e-02 | 114 | 30 | 2 | 2.60.40.60 | |
| Domain | CA | 1.46e-02 | 115 | 30 | 2 | SM00112 | |
| Pubmed | 6.48e-11 | 9 | 31 | 4 | 21670307 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 16990264 | ||
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 6.41e-10 | 3 | 31 | 3 | 29458010 | |
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 18005988 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 23585851 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 24477688 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 19776007 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 6.41e-10 | 3 | 31 | 3 | 29433546 | |
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 26582205 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 37105392 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 9153289 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 33316546 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 18974023 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 9038233 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 23144904 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 6.41e-10 | 3 | 31 | 3 | 29651447 | |
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 36479526 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 28704475 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 21146220 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 6.41e-10 | 3 | 31 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 6.41e-10 | 3 | 31 | 3 | 33923930 | |
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 6.41e-10 | 3 | 31 | 3 | 25898318 | |
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 31937306 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 21426359 | ||
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 6.41e-10 | 3 | 31 | 3 | 31969388 | |
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 23836896 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 18282810 | ||
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 6.41e-10 | 3 | 31 | 3 | 35241678 | |
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 6.41e-10 | 3 | 31 | 3 | 7890611 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 6.41e-10 | 3 | 31 | 3 | 22341088 | |
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 6.41e-10 | 3 | 31 | 3 | 28990062 | |
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 32380082 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 24083426 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 23667648 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 37279535 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 18579572 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 6.41e-10 | 3 | 31 | 3 | 25931247 | |
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 22627368 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 28877989 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 33153471 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 19800850 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 22052881 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 17560833 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 38987795 | ||
| Pubmed | 6.41e-10 | 3 | 31 | 3 | 35643073 | ||
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 6.41e-10 | 3 | 31 | 3 | 23408620 | |
| Pubmed | Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. | 2.56e-09 | 4 | 31 | 3 | 20463811 | |
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 38686388 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 22677125 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 32855403 | ||
| Pubmed | Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain. | 2.56e-09 | 4 | 31 | 3 | 23657851 | |
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 19234217 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 18826117 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 24333756 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 38853593 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 35715604 | ||
| Pubmed | Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. | 2.56e-09 | 4 | 31 | 3 | 24958847 | |
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 19017954 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 30120235 | ||
| Pubmed | Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation. | 2.56e-09 | 4 | 31 | 3 | 33963043 | |
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 2.56e-09 | 4 | 31 | 3 | 36459823 | |
| Pubmed | [Expression of Galectin-9 and Tim-3 in lungs of mice with asthma]. | 2.56e-09 | 4 | 31 | 3 | 21575348 | |
| Pubmed | Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. | 2.56e-09 | 4 | 31 | 3 | 18346632 | |
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 11839756 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 33107565 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 19670381 | ||
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 2.56e-09 | 4 | 31 | 3 | 29611821 | |
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 30763585 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 25450716 | ||
| Pubmed | The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. | 2.56e-09 | 4 | 31 | 3 | 16286920 | |
| Pubmed | Galectin-9 regulates the threshold of B cell activation and autoimmunity. | 2.56e-09 | 4 | 31 | 3 | 34369876 | |
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 2.56e-09 | 4 | 31 | 3 | 33727589 | |
| Pubmed | Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. | 2.56e-09 | 4 | 31 | 3 | 19362679 | |
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 33203936 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 25578313 | ||
| Pubmed | 2.56e-09 | 4 | 31 | 3 | 29844236 | ||
| Pubmed | Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. | 2.56e-09 | 4 | 31 | 3 | 22021615 | |
| Pubmed | Embryonic implantation in galectin 1/galectin 3 double mutant mice. | 6.40e-09 | 5 | 31 | 3 | 9566950 | |
| Pubmed | 6.40e-09 | 5 | 31 | 3 | 29242193 | ||
| Pubmed | 6.40e-09 | 5 | 31 | 3 | 28951537 | ||
| Pubmed | 6.40e-09 | 5 | 31 | 3 | 26278059 | ||
| Pubmed | Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner. | 6.40e-09 | 5 | 31 | 3 | 34847625 | |
| Pubmed | 6.40e-09 | 5 | 31 | 3 | 22469568 | ||
| Pubmed | 6.40e-09 | 5 | 31 | 3 | 37352334 | ||
| Pubmed | 6.40e-09 | 5 | 31 | 3 | 33664349 | ||
| Pubmed | The glucose transporter 2 regulates CD8+ T cell function via environment sensing. | 6.40e-09 | 5 | 31 | 3 | 37884694 | |
| Pubmed | 6.40e-09 | 5 | 31 | 3 | 25158758 | ||
| Pubmed | 6.40e-09 | 5 | 31 | 3 | 21385853 | ||
| Pubmed | C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells. | 6.40e-09 | 5 | 31 | 3 | 19782405 | |
| Pubmed | Tim3 binding to galectin-9 stimulates antimicrobial immunity. | 1.28e-08 | 6 | 31 | 3 | 20937702 | |
| Pubmed | 1.28e-08 | 6 | 31 | 3 | 8674632 | ||
| Pubmed | 1.28e-08 | 6 | 31 | 3 | 28394331 | ||
| Pubmed | 1.28e-08 | 6 | 31 | 3 | 23296703 | ||
| Pubmed | Role of galectin-1 in the developing mouse olfactory system. | 2.24e-08 | 7 | 31 | 3 | 8873770 | |
| Pubmed | 3.58e-08 | 8 | 31 | 3 | 31661141 | ||
| Pubmed | 3.58e-08 | 8 | 31 | 3 | 23751344 | ||
| Pubmed | 3.58e-08 | 8 | 31 | 3 | 36883358 | ||
| Pubmed | Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. | 5.37e-08 | 9 | 31 | 3 | 25065622 | |
| Pubmed | 1.40e-07 | 12 | 31 | 3 | 23817958 | ||
| Interaction | SLC12A4 interactions | 2.15e-05 | 129 | 26 | 4 | int:SLC12A4 | |
| Interaction | PHYHD1 interactions | 4.46e-05 | 8 | 26 | 2 | int:PHYHD1 | |
| Interaction | RRAGB interactions | 4.53e-05 | 54 | 26 | 3 | int:RRAGB | |
| Interaction | ABCC4 interactions | 5.05e-05 | 56 | 26 | 3 | int:ABCC4 | |
| Interaction | UPK1B interactions | 6.53e-05 | 61 | 26 | 3 | int:UPK1B | |
| Interaction | SLC12A2 interactions | 1.08e-04 | 195 | 26 | 4 | int:SLC12A2 | |
| Interaction | RRAGC interactions | 1.21e-04 | 75 | 26 | 3 | int:RRAGC | |
| Cytoband | 1p36.31 | 4.00e-05 | 14 | 31 | 2 | 1p36.31 | |
| Cytoband | 5q31 | 2.76e-03 | 115 | 31 | 2 | 5q31 | |
| Cytoband | 17p11.2 | 5.19e-03 | 159 | 31 | 2 | 17p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p11 | 8.32e-03 | 203 | 31 | 2 | chr17p11 | |
| GeneFamily | Galectins | 8.10e-07 | 15 | 23 | 3 | 629 | |
| GeneFamily | Clustered protocadherins | 2.97e-03 | 64 | 23 | 2 | 20 | |
| GeneFamily | PHD finger proteins | 5.79e-03 | 90 | 23 | 2 | 88 | |
| Coexpression | NABA_ECM_AFFILIATED | 3.08e-05 | 158 | 30 | 4 | MM17063 | |
| Coexpression | NABA_ECM_AFFILIATED | 4.10e-05 | 170 | 30 | 4 | M5880 | |
| Coexpression | GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_DN | 7.00e-05 | 195 | 30 | 4 | M9309 | |
| Coexpression | MORI_MATURE_B_LYMPHOCYTE_DN | 1.17e-04 | 83 | 30 | 3 | MM596 | |
| Coexpression | BURTON_ADIPOGENESIS_9 | 1.44e-04 | 89 | 30 | 3 | MM1026 | |
| Coexpression | MORI_LARGE_PRE_BII_LYMPHOCYTE_UP | 1.64e-04 | 93 | 30 | 3 | MM1137 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 2.03e-04 | 100 | 30 | 3 | MM514 | |
| Coexpression | WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION | 2.38e-04 | 20 | 30 | 2 | M11268 | |
| Coexpression | QI_PLASMACYTOMA_UP | 2.48e-04 | 271 | 30 | 4 | MM1045 | |
| Coexpression | OKAWA_NEUROBLASTOMA_1P36_31_DELETION | 2.88e-04 | 22 | 30 | 2 | M4786 | |
| Coexpression | MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP | 3.06e-04 | 115 | 30 | 3 | MM599 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500_k-means-cluster#4 | 6.38e-05 | 57 | 29 | 3 | JC_hmvEC_500_K4 | |
| CoexpressionAtlas | rectum | 7.69e-05 | 168 | 29 | 4 | rectum | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.63e-06 | 194 | 31 | 4 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.63e-06 | 194 | 31 | 4 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-05 | 198 | 31 | 4 | efdbac7a3a02bff4ca48841772e0c136556c2b9b | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-05 | 198 | 31 | 4 | a631be84e29c277216d89ec6265bd43e87c1dc86 | |
| Disease | response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy | 9.60e-04 | 54 | 25 | 2 | EFO_0000180, EFO_0003100, GO_0061479 | |
| Disease | lung cancer (is_implicated_in) | 1.79e-03 | 74 | 25 | 2 | DOID:1324 (is_implicated_in) | |
| Disease | Abnormality of refraction | 2.32e-03 | 673 | 25 | 4 | HP_0000539 | |
| Disease | sleep quality | 4.48e-03 | 118 | 25 | 2 | EFO_0005272 | |
| Disease | pelvic organ prolapse | 5.90e-03 | 136 | 25 | 2 | EFO_0004710 | |
| Disease | facial height measurement | 6.42e-03 | 142 | 25 | 2 | EFO_0007856 | |
| Disease | cytokine measurement | 6.75e-03 | 461 | 25 | 3 | EFO_0004873 | |
| Disease | insomnia, total blood protein measurement | 6.95e-03 | 148 | 25 | 2 | EFO_0004536, EFO_0004698 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GIKPFACPCKMECYM | 306 | Q6PI77 | |
| QYLCMPLPDALMCVV | 96 | Q8NFU1 | |
| PMKVVDMFGCCLPVC | 376 | Q9BT22 | |
| MMDLKKCCNHPYLFP | 986 | Q8TDI0 | |
| CIKMPYLPGLQSCQK | 56 | P0DMQ9 | |
| LPMKVVDMFGCCLPV | 71 | Q6GMV1 | |
| VLMCGPPPMIQYACL | 271 | P00387 | |
| YCTPGLCQFMAMLPT | 11 | A6NJW4 | |
| NKMCPNYFIPQCNML | 371 | Q8IYB1 | |
| MPFQKGMPFDLCFLV | 91 | Q6DKI2 | |
| MPFQKGMPFDLCFLV | 91 | Q3B8N2 | |
| MPFQKGMPFDLCFLV | 91 | O00182 | |
| LAVLPMPQPCYCMEA | 181 | Q6X9E4 | |
| CGPKEPCMLYFQILM | 96 | Q9UN67 | |
| APFGVMLCAYMCILN | 206 | Q9Y5Y3 | |
| YMPPLCDPKDGHLLM | 1066 | Q6ZV29 | |
| AMMAVDPYVAICKPL | 116 | Q8NH90 | |
| TPGCIRALMKMLYCP | 241 | Q9Y625 | |
| LAKAMPTFLQMCEPY | 121 | A6NJJ6 | |
| PMDCPAALYQLMLDC | 846 | P29320 | |
| PMYLMRKPACGLCQL | 306 | Q9Y4D2 | |
| NPCYDMKTTCLPMFG | 201 | P05106 | |
| MCKNLIGTFMCICPP | 2311 | P35556 | |
| CYCPGMPNIFNFMPI | 981 | P20648 | |
| AFYCMKPQHMPCEAL | 241 | Q8N323 | |
| CGPKEPCMLYFQILM | 96 | Q9Y5E1 | |
| CPVCLQYFAEPMMLD | 16 | P14373 | |
| MFNGSKLKCPYCPME | 366 | Q9H871 | |
| IMDMFCPPGIKIDAY | 586 | Q9NUX5 | |
| KAACIMCAYLKLLPM | 311 | Q9NY91 | |
| LFLCKSDPMAYLMVP | 796 | Q9BXU1 | |
| FCMKPFAGRPMIECN | 236 | Q86YI8 | |
| MSMKPYKCPFCEEGF | 1046 | Q9UL36 |